miR-505 suppresses prostate cancer progression by targeting NRCAM

por Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Publicado 2019

miR-505 suppresses prostate cancer progression by targeting NRCAM

por Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Publicado 2020

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

por LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE
Publicado 2016

miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein

por Huang, Ya-Qiang, Ling, Xiao-Hui, Yuan, Run-Qiang, Chen, Zhi-Yun, Yang, Sheng-Bang, Huang, Hong-Xing, Zhong, Wei-De, Qiu, Shao-Peng
Publicado 2017

Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients

por He, Hui-chan, Han, Zhao-dong, Dai, Qi-shan, Ling, Xiao-hui, Fu, Xin, Lin, Zhuo-yuan, Deng, Ye-han, Qin, Guo-qiang, Cai, Chao, Chen, Jia-hong, Jiang, Fu-neng, Liu, Xingyin, Zhong, Wei-de
Publicado 2013

SOXs in human prostate cancer: implication as progression and prognosis factors

por Zhong, Wei-de, Qin, Guo-qiang, Dai, Qi-shan, Han, Zhao-dong, Chen, Shan-ming, Ling, Xiao-hui, Fu, Xin, Cai, Chao, Chen, Jia-hong, Chen, Xi-bin, Lin, Zhuo-yuan, Deng, Ye-han, Wu, Shu-lin, He, Hui-chan, Wu, Chin-lee
Publicado 2012